Visit COVID-19 resources

[Skip to Content]

Reversible retinal toxicity in early oral Entecavir therapy for hepatitis-B infection – (Reversible retinal toxicity in early oral Entecavir therapy for hepatitis-B infection, Published online: 2018-06-22; | doi:10.1038/s41433-018-0156-6)

22 June 2018

This news item is available to RCOphth members only, please log in below to access.

Members Login